Daniel Sarmiento Garzon, MD
Colon & Rectal Surgery · Atlanta, GANPI 1841578416
Payments from drug & device makers
What this record shows
This record is dominated by education: $11,203 of the $13,518 with a category attached, or 82.9%. Intuitive Surgical accounts for 92.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $10,816 and has fallen 88.5% since, to $1,248 in 2025.
Across 48 payments — averaging $281.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- Davol Inc.$218
- Medtronic$217
- Lexington Medical, Inc.$154
- Boston Scientific$97
- Smith+Nephew$84
- plus $246 from 9 others
What the payments were for
- Travel & lodging$8286%
- Food & beverage$1,48711%
- Education$11,20383%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $12,501 |
| Davol Inc. | 2 | $218 |
| Medtronic | 7 | $217 |
| Lexington Medical, Inc. | 2 | $154 |
| Boston Scientific | 1 | $97 |
| Smith+Nephew | 4 | $84 |
| Osiris Therapeutics Inc. | 1 | $68 |
| Johnson & Johnson | 2 | $38 |
| Vertex | 1 | $30 |
| Innovation Technologies Inc | 1 | $25 |
| Abbott | 1 | $22 |
| Solventum Corporation | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| KCI USA, Inc. | 1 | $14 |
| THD America, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,518 in reported general payments places this provider in the 70th percentile of 66 colon & rectal surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 35 | $5,614 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 39 | $519 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 19 | $416 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $285 |
| Neomycin Sulfate | 35 | $173 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $168 |
| Metronidazole | 35 | $71 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $54 |
| Ondansetron Hcl | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Atlanta
- Patrick SullivanAtlanta$41K
- Sander BinderowAtlanta$20K
- Joseph MarenoAtlanta$13K
- Jessica LamAtlanta$8K
- Evan FeldmanAtlanta$7K
- Cici ZhangAtlanta$5K
- Ellen CaparosaAtlanta$5K
- Monica HumAtlanta$5K
- Gie YuAtlanta$3K
- Stephanie PappasAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.